HIV infection

  • Acquired immunodeficiency syndrome (AIDS) was first recognised in the USA in the 1970s
  • Human immunodeficiency virus (HIV) was isolated in 1983
  • In 1984 a serological test for antibodies to the virus became available
  • In 1996 WHO estimated worldwide that there were:
    • 3.1 million new cases of HIV infections
    • 29 million people were infected with HIV
  • In UK to date 58,000 have been HIV positive and 18,000 have developed AIDS
  • 30-50% of of HIV positive patients are unaware of their infection
  • HIV is a treatable disease
  • Where therapy is available infected individuals have the same rate of death as aged-matched uninfected controls

Immunology

  • HIV is a double-stranded RNA retrovirus
  • Attaches to human immune cells through the CD4 molecule
  • It produces DNA by the use of the enzyme reverse transcriptase
  • DNA is the incorporated into host cells
  • The incorporated viral DNA produces new viral components which are spliced and assembled using a viral protease
  • HIV infection results in widespread immunological dysfunction
  • It results in a fall in CD4 lymphocytes, monocytes and antigen-presenting cells
  • Immunological dysfunction results in opportunistic infections and increases risk of malignancy
  • The virus is transmitted in bodily fluids by
    • Heterosexual intercourse - Africa and Asia
    • Homosexual intercourse - UK and North America
    • Blood transfusions
    • Intravenous drug abuse
    • Perinatal transmission

Natural history

  • Up to three months there is often an asymptomatic viraemia
  • Patients are infective during this period
  • ELISA test for HIV antibodies are negative
  • At seroconversion an acute seroconversion illness (ASI) can occur
  • May be followed by persistent generalised lymphadenopathy (PGI)
  • Progression to symptomatic disease occurs within several years

  • AIDS develops within 5 to 10 years

  • AIDS diagnosed by the presence of an AIDS indicator disease with a positive HIV test

  • Median survival with AIDS is 2 years

  • 5% of HIV positive patients have remained well without therapy for more than 20 years

Serological changes with disease progression

Progression of HIV assocaited diseases

AIDS indicator diseases

  • Multiple recurrent bacterial infections
  • Tracheal or bronchial candidiasis
  • Invasive cervical carcinoma
  • Extrapulmonary or disseminated coccidiodomycosis
  • Cryptosporidiosis
  • Cytomegalovirus retinitis
  • HIV encephalopathy
  • Disseminated or extrapulmonary histoplasmosis
  • Kaposi's sarcoma
  • Lymphoma
  • Disseminated mycobacteriosis
  • Pneumocystis carinii pneumonia
  • Progressive multifocal leukoencephalopathy
  • Cerebral toxoplasmosis

Sites of pyogenic infections in AIDS

  • Thoracic empyema
  • Anorectal abscesses
  • Skin boils, carbuncles and cellulitis
  • Necrotising fasciitis
  • Pyomyositis
  • Osteomyelitis
  • Septic arthritis
  • Epididymo-orchitis
  • Pelvic inflammatory disease
  • Appendicitis

Treatment

  • HIV therapies are available that:
    • Prevent virus entry into cells
    • Inhibit viral reverse transcriptase
    • Inhibit viral protease
  • Combination therapy with anti-HIV drugs:
    • Inhibits viral replication
    • Reduces viraemia to undetectable levels
    • Leads to reconstitution of immune dysfunction
    • Prevents opportunistic disease
  • Stopping therapy leads to re-emergence of viraemia

Bibliography

Jaffray C E,  Flint L M.  Blood-borne viral diseases and the surgeon.  Curr Probl Surg 2003;  40:  195-251.

 

 
 

Last updated: 05 January 2008

Copyright © 1997- 2008 Surgical-tutor.org.uk